HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of
International Ophthalmology Conference
March 10-12, 2025 | Rome, Italy
Ophthalmological Therapies
Ophthalmological Therapies
Ophthalmology is a medical and surgical specialty that focuses on the diagnosis and treatment of eye problems. A physician who specializes in ophthalmology is known as an ophthalmologist. Academic research on the diagnosis and treatment of eye problems is available to ophthalmologists. Combining methods and therapies to address diverse pathologic processes has become commonplace in many, if not all, medical specialties. Gene therapy is a prominent topic in ophthalmic research because it has the potential to be a one-time transformative therapy for patients with wet AMD who have unmet medical requirements.
- Ophthalmological Therapies
- Ophthalmological Devices
- Ophthalmological Surgical Techniques
- Physical Therapy
- Combination Therapy
- Gene Therapy
Committee Members
John David Bullock
Wright State University, United States
Minckler Don S
UCI Gavin Herbert Eye Institute, United States
Kasra Rezaei
University of Washington, United States IOC 2025 Speakers
Dhruva Drew Gupta
Harvard Medical School, United States
Nour Abou Shousha
Harvard Medical School, United States
George HH Beiko
McMaster Univeresity, Canada
Mustafa Al Ghazi
University Hospital of Wales, United KingdomSubmit your abstract Today
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI Gavin Herbert Eye Institute, United States
Title : Eyes and guts connection: Microbiomes and their role in ocular health
Edward Charles Kondrot, Healing the Eye Wellness Center, United States
Title : Ultra-Widefield protocol enhances automated classification of diabetic retinopathy severity with OCT angiography
Kasra Rezaei, University of Washington, United States
Title : Why was Leonhard Euler blind?
John David Bullock, Wright State University, United States
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Developing resilience-based treatments for glaucoma
Simon John, Columbia University, United States